CVS Caremark Price Target Increased to $71.00 by Analysts at Cantor Fitzgerald (CVS)
Equities researchers at Cantor Fitzgerald increased their price target on shares of CVS Caremark (NYSE:CVS) from $66.00 to $71.00 in a research report issued on Wednesday. Cantor Fitzgerald’s target price indicates a potential downside of 7.83% from the company’s current price.
CVS Caremark (NYSE:CVS) traded down 0.31% during mid-day trading on Wednesday, hitting $77.03. 11,306,321 shares of the company’s stock traded hands. CVS Caremark has a 52 week low of $56.32 and a 52 week high of $79.43. The stock has a 50-day moving average of $76.91 and a 200-day moving average of $74.23. The company has a market cap of $90.356 billion and a P/E ratio of 19.68. CVS Caremark also was the recipient of some unusual options trading activity on Monday. Investors acquired 7,359 put options on the company. This is an increase of 776% compared to the typical daily volume of 840 put options.
CVS Caremark (NYSE:CVS) last posted its quarterly earnings results on Tuesday, August 5th. The company reported $1.13 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.10 by $0.03. The company had revenue of $34.60 billion for the quarter, compared to the consensus estimate of $33.47 billion. During the same quarter in the prior year, the company posted $0.97 earnings per share. The company’s quarterly revenue was up 10.7% on a year-over-year basis. On average, analysts predict that CVS Caremark will post $4.47 earnings per share for the current fiscal year.
A number of other analysts have also recently weighed in on CVS. Analysts at Morgan Stanley raised their price target on shares of CVS Caremark from $81.00 to $85.00 in a research note on Wednesday. Separately, analysts at Barclays raised their price target on shares of CVS Caremark from $85.00 to $87.00 in a research note on Wednesday. Finally, analysts at Leerink Swann raised their price target on shares of CVS Caremark from $85.00 to $87.00 in a research note on Wednesday. One analyst has rated the stock with a sell rating, three have issued a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus target price of $80.48.
CVS Caremark Corporation (NYSE:CVS), together with its subsidiaries, is a pharmacy health care provider in the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.